A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Clinical trial NCT01605825 · COMPLETED
Trial details
- NCT number
- NCT01605825
- Sponsor
- Acorda Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2013-02-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.